SynthesisCardiovascular drugs and therapy2025

Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials.

Daniel A Gomes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.